Urban, M. O. and G. F. Gebhart. Characterization of biphasic that the RVM both facilitates and inhibits spinal nociceptive transmission, and they complement previous work showing that neuromodulation of spinal nociceptive transmission by neurotensin in tensin in the RVM modulates spinal nociceptive behavioral rethe rat rostral ventromedial medulla. J. Neurophysiol. 78: 1550Neurophysiol. 78: -sponses. 1562Neurophysiol. 78: , 1997. Modulation of spinal nociceptive transmission by neurotensin microinjected in the rostral ventromedial medulla (RVM) was examined in anesthetized, paralyzed rats. Forty-three spinal stimulation (50ЊC) that lasted Ç12 min. In contrast, injection of supraspinal site that modulates spinal nociceptive transmisgreater doses of neurotensin (300 or 3,000 pmol) produced an sion and includes the nucleus raphe magnus, nucleus reticuinhibition of spinal unit responses to noxious heat (51.7 and 10.6% laris gigantocellularis, and nucleus reticullaris paragigantoof control, respectively) that had a longer duration (60-120 min). cellularis lateralis (Fields et al. 1991) . Initial investigations The effects of neurotensin on wide-dynamic-range and nociceptive-of the role of the RVM in nociceptive processing focused specific neuron responses to noxious heat were qualitatively and on inhibition of spinal nociception, because this area was quantitatively similar. Spinal unit responses to graded heating of implicated as an important relay in an endogenous descendthe skin (42-50ЊC) were completely inhibited after microinjection ing pain inhibitory system originating from the midbrain Gebhart (1990a, 1992) demonstrated that loweral funiculus (DLF) significantly reduced the inhibition of spinal intensity electrical stimulation or low-dose glutamate injecnociceptive transmission produced by neurotensin (3,000 pmol) in tion into the RVM facilitates spinal behavioral and dorsal the RVM, whereas bilateral transection of the DLFs completely horn neuron responses to noxious thermal stimulation. In blocked the effect. In contrast, bilateral transection of the DLFs contrast, greater-intensity electrical stimulation or greater had no effect on facilitation of spinal nociception by neurotensin doses of glutamate at the same sites in the RVM inhibit (0.03 pmol) in the RVM. The inhibition of spinal nociceptive these responses. Descending facilitatory and inhibitory systransmission by neurotensin (3,000 pmol) in the RVM was com-tems from the RVM have been found to be anatomically pletely blocked by injection of the nonpeptide neurotensin receptor independent; facilitation of spinal nociception involves deantagonist SR48692 (30 fmol) into the RVM 10 min before neuroscending axons in the ventrolateral funiculi (VLF), whereas tensin. To confirm a specific block of neurotensin-receptor-mediinhibition is mediated via axons in the dorsolateral funiculi ated effects by the antagonist, a subsequent injection of L-glutamate (DLF) Gebhart 1991a, 1992). These anatomiinto the RVM was performed. L-Glutamate (100 nmol) was found to inhibit the nociceptive responses of those spinal units whose cally independent descending facilitatory and inhibitory sysresponses were no longer inhibited by neurotensin. In contrast, tems appear to involve different spinal mediators (Ren et injection of SR48692 (30 fmol) into the RVM failed to block the al. 1991; Gebhart 1990b, 1991b) and may also be facilitation of spinal unit responses to noxious heat produced by a related to physiologically distinct classes of neurons within subsequent injection of neurotensin (0.03 pmol) into the same site. the RVM (Fields et al. 1991) . Thus facilitation and inhibiThe present series of experiments demonstrate a specific role for tion of spinal nociceptive transmission from the RVM inneurotensin in the RVM in the modulation of spinal nociceptive volves distinct, independent systems that may be anatomitransmission, because the peptide was found to both facilitate and cally, pharmacologically, and physiologically differentiated.
It is well established that spinal nociceptive input is modusurface of the ipsilateral hind foot were studied. Spinal units were lated by systems that descend from supraspinal sites in the classified as either wide dynamic range or nociceptive specific and CNS (for reviews see Basbaum and Fields 1984; were located in spinal laminae I-V. Microinjection of neurotensin and Randich 1990; Hammond 1986 ). The rostral ventrome-(0.03 pmol/0.2 ml) into the RVM produced a significant facilitation dial medulla (RVM) has been identified as an important (135% of control) of spinal unit responses to noxious thermal stimulation (50ЊC) that lasted Ç12 min. In contrast, injection of supraspinal site that modulates spinal nociceptive transmisgreater doses of neurotensin (300 or 3,000 pmol) produced an sion and includes the nucleus raphe magnus, nucleus reticuinhibition of spinal unit responses to noxious heat (51.7 and 10.6% laris gigantocellularis, and nucleus reticullaris paragigantoof control, respectively) that had a longer duration (60-120 min). cellularis lateralis (Fields et al. 1991) . Initial investigations The effects of neurotensin on wide-dynamic-range and nociceptive-of the role of the RVM in nociceptive processing focused specific neuron responses to noxious heat were qualitatively and on inhibition of spinal nociception, because this area was quantitatively similar. Spinal unit responses to graded heating of implicated as an important relay in an endogenous descendthe skin (42-50ЊC) were completely inhibited after microinjection ing pain inhibitory system originating from the midbrain of 3,000 pmol of neurotensin into the RVM. Injection of a lesser periaqueductal gray (Basbaum and Fields 1984) .
dose of neurotensin (300 pmol), however, resulted in a partial Recent studies, however, have demonstrated that the RVM inhibition of spinal unit responses and significantly reduced the both inhibits and facilitates spinal nociceptive transmission.
slope of the stimulus-response function to graded heating of the skin. Transection of either the ipsilateral or contralateral dorsolat- Gebhart (1990a, 1992) demonstrated that loweral funiculus (DLF) significantly reduced the inhibition of spinal intensity electrical stimulation or low-dose glutamate injecnociceptive transmission produced by neurotensin (3,000 pmol) in tion into the RVM facilitates spinal behavioral and dorsal the RVM, whereas bilateral transection of the DLFs completely horn neuron responses to noxious thermal stimulation. In blocked the effect. In contrast, bilateral transection of the DLFs contrast, greater-intensity electrical stimulation or greater had no effect on facilitation of spinal nociception by neurotensin doses of glutamate at the same sites in the RVM inhibit (0.03 pmol) in the RVM. The inhibition of spinal nociceptive these responses. Descending facilitatory and inhibitory systransmission by neurotensin (3,000 pmol) in the RVM was com-tems from the RVM have been found to be anatomically pletely blocked by injection of the nonpeptide neurotensin receptor independent; facilitation of spinal nociception involves deantagonist SR48692 (30 fmol) into the RVM 10 min before neuroscending axons in the ventrolateral funiculi (VLF), whereas tensin. To confirm a specific block of neurotensin-receptor-mediinhibition is mediated via axons in the dorsolateral funiculi ated effects by the antagonist, a subsequent injection of L-glutamate (DLF) Gebhart 1991a, 1992) . These anatomiinto the RVM was performed. L-Glutamate (100 nmol) was found to inhibit the nociceptive responses of those spinal units whose cally independent descending facilitatory and inhibitory sysresponses were no longer inhibited by neurotensin. In contrast, tems appear to involve different spinal mediators (Ren et injection of SR48692 (30 fmol) into the RVM failed to block the al. 1991; Gebhart 1990b, 1991b) and may also be facilitation of spinal unit responses to noxious heat produced by a related to physiologically distinct classes of neurons within subsequent injection of neurotensin (0.03 pmol) into the same site. the RVM (Fields et al. 1991) . Thus facilitation and inhibiThe present series of experiments demonstrate a specific role for tion of spinal nociceptive transmission from the RVM inneurotensin in the RVM in the modulation of spinal nociceptive volves distinct, independent systems that may be anatomitransmission, because the peptide was found to both facilitate and cally, pharmacologically, and physiologically differentiated.
inhibit spinal neuron responses to noxious thermal stimulation.
In previous studies, we focused on the role of neurotensin Additionally, the facilitatory and inhibitory effects of neurotensin in the RVM in the modulation of spinal nociceptive behavappear to occur via interaction with multiple neurotensin receptors ioral responses. Neurotensin is a tridecapeptide that is disin the RVM that activate independent systems that descend in the tributed throughout the CNS, including the RVM, and has ventrolateral funiculi and DLFs, respectively. The results from these experiments are consistent with prior studies demonstrating been implicated in pain modulation (Behbehani 1992; Beitz were isolated with the use of a window discriminator, amplified 1982a; Jennes et al. 1982) . Following intracisternal administhrough a low-noise amplifier, and displayed on an oscilloscope, tration or microinjection into various brain loci, neurotensin and responses were quantified on-line with the use of a computer was found to produce antinociception in models of both (CED; Spike2 Analysis software).
cutaneous and visceral nociception (Clineschmidt and McGuffin 1977; Kalivas et al. 1982) . Additionally, in a Noxious stimulation preliminary study, injection of neurotensin into the RVM was found to dose-dependently inhibit the spinal nociceptive Mechanical stimulation (touch, brush, or pinch) of the plantar tail-flick reflex in anesthetized rats (Fang et al. 1987) . Re-surface of the ipsilateral hind foot was used as a search stimulus cent studies investigating effects of neurotensin in the RVM for neurons in the L 3 -L 5 spinal segments. Neurons were classified as wide dynamic range on the basis of their ability to respond to on spinal nociceptive transmission demonstrated neurotensin noxious pinch with the use of forceps and noxious heat (50ЊC) to have a biphasic effect on the spinal tail-flick reflex, beas well as nonnoxious light touch (light pressure and brush).
cause injection of lesser doses facilitates the response Nociceptive-specific neurons were identified on the basis of their whereas greater doses inhibit it (Urban and Smith 1993).
ability to respond to noxious pinch and heat, but not nonnoxious An interaction of neurotensin with independent descending light touch. Isolated units were subsequently tested for responfacilitatory and inhibitory systems is supported by the obser-siveness to noxious heat (50ЊC) in the center of the receptive field. vation that these dual effects are anatomically differentiated Radiant heat was supplied from a projector lamp containing a within the RVM (Urban and Smith 1994). Additionally, copper-constantan thermocouple to allow feedback control for sedescending facilitation and inhibition of spinal nociceptive lection of specific temperatures. Heat stimuli were applied for a transmission by neurotensin in the RVM involves different 10-s duration at 3-min intervals to minimize tissue damage and allow stable unit responses throughout the experiment.
spinal mediators .
The present series of experiments were designed to expand on the behavioral data by investigating the effects of neuro-Microinjection procedure tensin in the RVM on spinal dorsal horn neuron responses Microinjection of drugs into the RVM was performed by lowto noxious thermal stimulation. A limitation of behavioral ering a 33-gauge needle through the guide cannula and delivering nociceptive tests is that the response involves both a sensory 0.2 ml of drug during 30 s. A Hamilton 10-ml syringe was connected and motor component. Therefore, to preclude any effect of to the injection needle with polyethylene tubing (PE 10) containing neurotensin on motor function, these experiments directly an air bubble to monitor flow of the drug solution. focus on effects of neurotensin in the RVM on spinal nociceptive sensory input.
Spinal DLF transection
The cervical spinal cord was exposed, and a small amount of
Gelfoam, soaked in dilute lidocaine, was applied. The ipsilateral and/or contralateral DLF was then pinched with the use of a pair
Animal preparation
of fine forceps (Janss and Gebhart 1988). Adult male Sprague-Dawley rats (400-450 g; Harlan, Indianapolis, IN) were used in all experiments. Animals were anesthetized Histology with an intraperitoneal injection of pentobarbital sodium (45) (46) (47) (48) (49) (50) At the conclusion of each experiment, rats were killed with an mg/kg) and catheters were inserted into the trachea for mechanical intravenous overdose of pentobarbital sodium, and anodal electroventilation, into the femoral vein to administer drugs, and into the lytic lesions were made in the spinal cord to mark the site of spinal femoral artery for measurement of blood pressure and heart rate recording. All neurons that were studied were located in dorsal (HR). Animals were paralyzed with pancuronium bromide (0.2 horn laminae I-V, 0-1,100 mm from the dorsum of the spinal cord. mg iv) and mechanically ventilated for the remainder of the exMethylene blue was injected into the site of drug administration in periment with room air. Anesthesia was maintained with a conthe RVM. The brain and spinal cord were removed, stored in 10% tinuous intravenous infusion of pentobarbital sodium (3-10 Formalin, and frozen, and coronal sections were cut for histological mgrkg 01 rh 01 ) and supplemental doses of pancuronium bromide verification of injection, transection, and recording sites. (0.2 mg iv) were administered to maintain paralysis. Arterial blood pressure and HR were continuously monitored, and the animals were kept at physiological temperatures with a hot-water heating Data and statistics pad and overhead lamps. The lumbar and upper sacral spinal cord was exposed by laminectomy between vertebrae T 13 and L 4 , and Spontaneous unit activity was counted for the initial 10-s period of analysis followed by total number of unit responses to noxious the animal was suspended in vertebral clamps with the head fixed in a stereotaxic apparatus. The dura mater was cut, and skin flaps heat during a 15-s period beginning at the onset of stimulation (peristimulus time histogram, 1-s binwidth). These recordings were tied to the stereotaxic frame to form a pool in which warm mineral oil (37ЊC) was placed to prevent dehydration. A guide were made for three consecutive trials, with an intertrial interval of 3 min. The total number of counts during the period of stimulacannula through which drugs could be delivered (26-gauge needle shaft) was stereotaxically implanted and maintained 3 mm above tion (10 s), and 5 s thereafter, were averaged for the three trials (counts/15 s). The response was considered stable if the intratrial the medial RVM (nucleus raphe magnus). The final coordinates for the RVM relative to the interaural line were 02.0 mm rostral-variation was õ10%. Stimulus-response functions were generated for various intensities of heat stimulation (42-50ЊC) with the data caudal, 0 mm medial-lateral, and 09.5 mm dorsal-ventral ( both wide-dynamic-range and nociceptive-specific spinal units. In addition, facilitation and inhibition of responses to the predrug (control) response. Dose-response relationships were noxious heat by neurotensin in the RVM were both qualitagenerated by recording responses following neurotensin injection tively and quantitatively similar for wide-dynamic-range and at the time of maximal effect (represented as % of the control nociceptive-specific spinal units in laminae I-V (Table 1) . response). Effects of neurotensin on stimulus-response functions Accordingly, data from wide-dynamic-range and nocicepwere determined by generating a stimulus-response function during tive-specific neurons recorded in laminae I-V are reported the time period in which neurotensin's effects were stable and below as a single group. The data are represented as means { SE of measurement. Com-DOSE AND TIME DEPENDENCE. After characterization of spiparisons between two groups were performed with the use of a nal unit responses to noxious heat, neurotensin (0.2 ml) was t-test, whereas statistical analysis for multiple comparisons was microinjected into the medial RVM (nucleus raphe magnus) carried out with the use of analysis of variance with Fisher's test (Fig. 1) . Injection of 0.03 pmol neurotensin into the RVM for post hoc comparisons. The slopes of stimulus-response func-produced a facilitation of spinal unit responses ( n Å 6) to tions were determined by linear regression with the use of a curve-noxious heat; an example is illustrated in Fig. 2 . The facilitafitting computer program (Graphpad Inplot). A P value õ0.05 tory effect had a relatively short duration of 15 min and was was considered statistically significant in all tests. maximal (135.0 { 8% of control, mean { SE) 3 min after injection (data summarized in Fig. 5 ). Microinjection of a Drugs greater dose of neurotensin (3,000 pmol) into the RVM significantly inhibited spinal unit responses (n Å 6) to noxDrugs used in the present series of experiments were neuroten-ious heat; an example is illustrated in Fig. 3 . Inhibition of sin, L-glutamate, and sodium nitroprusside (Sigma Chemical, St. spinal nociception was maximal 9 min after injection Louis, MO) and SR48692 (provided as a gift from Sanofi Re-(10.6 { 5% of control) and had a duration of action of 60-cherche, Toulouse, France). All drugs were dissolved in saline, 120 min (data summarized in Fig. 5 ). In 50% of the spinal with the exception of SR48692, which was dissolved in 20% diunits studied (3 of 6), 3,000 pmol of neurotensin completely methyl sulfoxide. The lack of effect of vehicle injection into the RVM was previously determined. to noxious heat were significantly attenuated, but not inhib-graded heat could not be determined because of the short duration of this effect. ited after injection of 300 pmol neurotensin ( n Å 6) into the RVM (51.7 { 6% of control); an example is illustrated TACHYPHYLAXIS. Because we planned to study the effects in Fig. 4 (data are summarized in Fig. 5 ).
of neurotensin before and after transection of the DLF, the effects of multiple injections of neurotensin in the RVM on INTENSITY CODING. The effects of neurotensin injection into the RVM on the stimulus-response function to graded heat-spinal unit responses to noxious heat were determined in a separate series of experiments. Following injection of a ing (42-50ЊC) of the ipsilateral hind foot were determined in 12 experiments during the time that the response to neuro-facilitatory dose of neurotensin (0.03 pmol), a subsequent injection of neurotensin (0.03 pmol) was made 15 min later, tensin was near maximal and relatively stable (between 6 and 24 min). Injection of neurotensin (3,000 pmol; n Å 6) after the response to heat had returned to the basal level. In all cases, this subsequent neurotensin injection was found into the RVM significantly reduced the slope of the stimulusresponse function to graded heating (from 12.0 { 0.7 to to have no effect (Fig. 7) . To preclude the possibility of nonselective damage to the injection area, a third injection 1.2 { 0.1%/deg C; Fig. 6 ) and completely inhibited responses to all intensities of thermal stimulation in four of of an inhibitory dose of neurotensin (300 pmol) was made into the RVM. In all cases (n Å 3), the inhibitory effect of six spinal units. Injection of a lesser dose of neurotensin (300 pmol; n Å 6) partially inhibited responses at all stimulation neurotensin was apparent and did not differ in magnitude from the effect produced by 300 pmol neurotensin given as intensities, resulting in a significantly reduced slope for the stimulus-response function to graded heat (from 12.0 { 0.7 a first injection (Fig. 7) . Similarly, in one experiment following injection of an inhibitory dose of neurotensin (300 to 7.4 { 0.9%/deg C; Fig. 6 ). The effects of a facilitatory dose of neurotensin on the stimulus-response function to pmol) into the RVM, a subsequent injection of the same dose 60 min later was found to be ineffective, whereas a neurotensin (3,000 pmol) into the RVM was apparent, but significantly attenuated after transection of the ipsilateral DLF third injection of a facilitatory dose (0.03 pmol) of neurotensin was still effective (data not shown). (Fig. 8A) . A subsequent transection of the contralateral DLF (resulting in a final bilateral transection) during the period of action of neurotensin completely reversed the remaining Descending pathways mediating neurotensin effects from inhibition of spinal nociceptive transmission by neurotensin in the RVM the RVM (Fig. 8A) . Similarly, initial transection of the DLF The effects of transection of the dorsolateral funicular tracts contralateral to the spinal recording site did not affect spontane-(DLF) on descending modulation of spinal nociception by ous activity (from 38 { 24 to 15 { 12 impulses/10 s) or heatneurotensin in the RVM were determined. In three experiments, evoked responses (from 366 { 122 to 336 { 130 impulses/ the effects of ipsilateral and subsequent bilateral DLF transec-15 s) of spinal units (n Å 3), but significantly attenuated the tion on neurotensin-induced inhibition of spinal nociceptive inhibition of spinal unit responses to noxious heat by neurotentransmission were determined. Following characterization of sin (3,000 pmol) in the RVM (Fig. 8B) . A subsequent transecspinal unit responses to noxious heat (50ЊC), transection of tion of the ipsilateral DLF (resulting in a bilateral transection) the DLF ipsilateral to the spinal recording site had no effect during the period of action of neurotensin completely blocked on either spontaneous activity (from 10.3 { 8 to 11 { 8.3 neurotensin-induced inhibition of spinal nociceptive transmisimpulses/10 s) or heat-evoked responses (from 169 { 51 to sion from the RVM (Fig. 8B) . effects of immediate bilateral transection of the DLF on tion, respectively) or heat-evoked responses of spinal units neurotensin-induced facilitation were determined (n Å 3). (440 { 123 and 456 { 146 impulses/15 s, pre-and postinAfter characterization of spinal unit responses to noxious jection, respectively, n Å 6). SR48692 (30 fmol) injected heat, the DLF were transected bilaterally. In contrast to neu-into the RVM 10 min before neurotensin (3,000 pmol), rotensin-induced inhibition, bilateral DLF transection had no however, completely blocked the inhibition of spinal unit effect on facilitation of spinal unit responses to noxious heat responses to noxious heat by neurotensin (n Å 3; Fig. 9A ). by injection of neurotensin (0.03 pmol) into the RVM To confirm a selective block of neurotensin-receptor-medi- (Fig. 8C) .
ated effects by SR48692, L-glutamate (100 nmol) was subsequently injected into the RVM. L-Glutamate injection into the RVM produced a rapid, short-lived inhibition of spinal Effects of a neurotensin receptor antagonist on unit responses to noxious heat following SR48692 and neuneurotensin responses rotensin injections (Fig. 9A) . In contrast to the effect of SR48692 on neurotensinTo determine whether the effects of neurotensin on spinal induced inhibition, injection of SR48692 ( 30 fmol ) into nociceptive transmission from the RVM are neurotensin rethe RVM 10 min before the facilitatory dose of neurotenceptor mediated, the effects of the nonpeptide neurotensin sin ( 0.03 pmol ) had no effect on neurotensin-induced fareceptor antagonist SR48692 injected into the RVM before cilitation of spinal nociception ( n Å 3; Fig. 9 B ) . A subseneurotensin were determined. Injection of SR48692 (30 quent injection of L-glutamate into the RVM was found fmol) into the RVM did not affect spontaneous activity to noxious heat, similar to that previously observed ( Fig. 9 B ) .
Effects of neurotensin on cardiovascular responses
Neurotensin microinjection into the RVM in doses that inhibited spinal nociceptive transmission (300 or 3,000 pmol) produced a dose-dependent decrease in mean arterial blood pressure (MAP) and HR ( Table 2) . Injection of a dose of neurotensin into the RVM that facilitated spinal nociceptive transmission (0.03 pmol), however, had no effect on either MAP or HR. To preclude the possibility that neurotensin-produced inhibition of spinal nociceptive transmission is due to changes in blood pressure and not to a direct effect on spinal sensory processing, the effect of the direct-acting vasodilator sodium nitroprusside on spinal unit FIG . 6 . A: individual stimulus-response functions of 12 spinal units to graded heating (42-50ЊC) of plantar surface of ipsilateral hind foot before NT injection. B: summary of stimulus-response functions in A normalized to % of control (% of response to 50ЊC) before NT injection (᭺) and after injection of 300 pmol (q, n Å 6) or 3,000 pmol (, n Å 6) NT into RVM. Slopes of stimulus-response functions were significantly reduced by both doses of NT (t-test, P õ 0.05). Data are expressed 15 min after injection of NT into RVM. responses to noxious heat was determined. Sodium nitroprusside was administered in a dose (8 mg/kg iv) that produced a decrease in MAP similar to that observed after injection of 3,000 pmol neurotensin into the RVM (DMAP Å 031.3 { 7.0 and 028.6 { 3.2 mmHg for neurotensin and sodium nitroprusside, respectively, n Å 3). In contrast to neurotensin, however, sodium nitroprusside had no effect on spinal unit responses to noxious thermal stimulation (n Å Effects of NT in RVM on spinal unit responses to noxious heat (50ЊC) following sequential injection of a facilitatory dose (0.03 pmol) followed by an inhibitory dose (300 pmol). Although a subsequent injection of 0.03 pmol was ineffective, 300 pmol significantly inhibited spinal unit responses to noxious heat (ANOVA, P õ 0.05, n Å 3). Data expressed as % of control (% of response to 50ЊC before NT) over time.
tion of spinal nociceptive transmission by neurotensin in the nociception, presumably via distinct, independent descend-RVM. Neurotensin is a neuropeptide that is localized within ing systems. Gebhart (1990a, 1992) reported that the RVM (Beitz 1982a) and is involved in nociceptive modula-low-intensity electrical stimulation or low doses of glutamate tion in the CNS (Behbehani 1992; Clineschmidt and McGuffin injected into the RVM facilitate spinal behavioral and dorsal 1977; Clineschmidt et al. 1979; Kalivas et al. 1982 ). An horn neuron responses to noxious stimulation, whereas involvement of neurotensin in the RVM in descending modula-greater-intensity electrical stimulation or greater doses of tion of spinal nociceptive transmission was identified in an glutamate inhibit these responses. Additionally, physiologiinitial study that found that neurotensin injection into the RVM cally distinct classes of neurons have been characterized in inhibited the spinal nociceptive tail-flick reflex in anesthetized the RVM on the basis of their activity during various condirats (Fang et al. 1987) . Subsequent studies in which the tail-tions of nociceptive responsiveness (Fields et al. 1991) . flick reflex in awake rats was measured demonstrated a biphasic ''OFF Cells'' have been identified as exhibiting increased effect of neurotensin in the RVM; microinjection of lesser activity during inhibition of nociception, and are thus bedoses (30 pmol) facilitated the tail-flick response, whereas lieved to mediate descending inhibition of nociception from greater doses (3-30 nmol) inhibited it (Urban and Smith the RVM. In contrast, ''ON cells'' show increased activity 1993). The present experiments were designed to more directly during periods of enhanced nociceptive responsiveness and determine effects of neurotensin in the RVM on spinal nocicep-are believed to mediate descending facilitation of nociceptive sensory processing by measuring responses of spinal dorsal tion. That two opposing effects on spinal nociceptive transhorn neurons to noxious thermal stimulation of the hind foot. mission may be produced from the RVM, presumably mediSimilar to the results obtained in behavioral studies, a lesser ated by distinct classes of neurons, suggests that facilitation dose of neurotensin (0.03 pmol) was found to facilitate spinal and inhibition of spinal nociceptive transmission from the dorsal horn neuron responses to noxious stimulation, whereas RVM involves distinct, independent descending systems. greater doses (300 or 3,000 pmol) inhibited these responses. This notion is further supported by the observation that deAdditionally, the time course of neurotensin effects in the pres-scending facilitation and inhibition involve different spinal ent study was comparable with results from behavioral studies; mediators; facilitation involves spinal serotonin 1 , kappa opifacilitation of nociception by neurotensin had a faster onset oid, and cholecystokinin B receptors, whereas inhibition inand shorter duration (15 min), whereas inhibition had a slower volves descending cholinergic and noradrenergic systems onset and longer duration (60-120 min). The doses of neuro- (Ren et al. 1991; ; Zhuo and Gebhart tensin required for modulation of spinal nociceptive transmis-1990b, 1991b) . Additionally, descending facilitation/inhibision were found to be less in the present study than reported tion of spinal nociceptive transmission by neurotensin apin previous behavioral studies (i.e., 10-fold less for inhibition pears to be anatomically differentiated within the RVM, beand 1,000-fold less for facilitation). One possible explanation cause descending inhibition is localized within the medial for this is that lesser doses may be required to affect the re-RVM (nucleus raphe magnus) whereas descending facilitasponse of a single spinal neuron, in contrast to an integrated tion involves a larger area of the RVM, including the nucleus behavioral response requiring the activity of multiple neurons. raphe magnus, nucleus reticularis gigantocellularis, and nucleus reticularis paragigantocellularis lateralis (Urban and Multiple descending systems from the RVM Smith 1994). In the current study, all microinjections were confined to the medial RVM (nucleus raphe magnus), and, The area of the RVM has been identified as an important supraspinal site that can both facilitate and inhibit spinal consistent with the behavioral studies, both facilitatory and inhibitory effects on spinal nociceptive transmission could in the current study (0.2 ml), the effects of neurotensin were likely occurring through an action in the medial RVM (nube elicited following neurotensin microinjection into this site. It is unlikely that the dual effects of neurotensin on cleus raphe magnus). Additionally, it was found that following injection of either an inhibitory or facilitatory dose of spinal nociceptive transmission are the result of diffusion to other sites. In previous studies in which dyes and radiola-neurotensin into the RVM, a subsequent injection of the identical dose was without effect, whereas injection of a beled substances were used, 0.5-ml intracerebral microinjections were found to diffuse through a volume of tissue having dose producing the opposite response was still effective.
These results suggest the occurrence of an acute desensitizaa radius of 0.5 mm from the injection site (Myers 1966; Myers and Hoch 1978) . The localization of neurotensin ef-tion or tachyphylaxis to neurotensin effects within the RVM.
That repeated stimulation of the same biological system may fects within the RVM is futher supported in a study that found that microinjection of 0.5 ml of neurotensin into the produce a tachyphylaxis is well documented (see O'Brien 1996 for review). Therefore the apparent lack of cross-tolernucleus raphe magnus produced antinociception, whereas microinjection of 1 mm bilaterally (nuclei reticularis paragi-ance between lesser and greater doses of neurotensin within the RVM further supports an interaction with distinct, indegantocellularis lateralis) was without effect (Urban and Smith 1994) . Given the smaller microinjection volume used pendent descending facilitatory and inhibitory systems.
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J723-6 / 9k16$$jy13 08-08-97 09:40:49 neupas LP-Neurophys tion of the VLF, however, was found to be ineffective in attenuating these responses (Jones and Gebhart 1987) . In contrast, facilitation of spinal nociceptive transmission by RVM or vagal afferent stimulation appears to be attenuated by VLF inactivation (Ren et al. 1989; Zhuo and Gebhart 1991a) . Although it is generally accepted that descending inhibition and facilitation are mediated via spinal DLF and VLF pathways, respectively, exceptions to this notion have been reported. Jones and Gebhart (1987) found descending inhibition from the locus coeruleus to involve the VLF and not the DLF. Furthermore, long-train DLF stimulation has been found to facilitate dorsal horn neuron responses (McMahon and Wall 1988) , and the DLF have been implicated in descending facilitation in a model of illness-induced hyperalgesia (Watkins et al. 1994) . In the present study, both ipsilateral and contralateral transection of the DLF was found to attenuate the inhibition of spinal nociceptive transmission produced by neurotensin (3,000 pmol) in the RVM. Bilateral transection of the DLF completely blocked neurotensin-induced inhibition of nociception. These results are consistent with those obtained in previous studies and suggest that neurotensin-induced inhibition of spinal nociceptive transmission is mediated bilaterally through the DLF. In contrast, bilateral transection of the DLF was ineffective in attenuating neurotensin-induced facilitation of nociception, suggesting that this effect is not mediated through the DLF and is likely occurring via descending tracts in the VLF. In the current study, DLF lesion alone had no effect on spinal neuron responses to noxious heat, which is consistent with results reported in other studies (Jones and Gebhart 1987; Zhuo and Gebhart 1992 ). There appears to be conflicting data regarding this subject, however, because certain other studies demonstrated that DLF lesion enhanced spinal nociceptive neuron responses and thereby revealed a tonic descending inhibitory influence (Pubols et al. 1991; Sandkuhler et al. 1987) . Although it is unclear why contradictory injected into RVM 10 min before NT (᭺: NT, n Å 3; q: SR48692 / NT, lack of effect of DLF lesions in the current study precludes n Å 3; ANOVA, P õ 0.05). A subsequent injection of L-glutamate (100 the possibility that effects on basal neuron responses account nmol) produced a significant inhibition of response (ANOVA, P õ 0.05). for the block of neurotensin-induced inhibition of spinal noData expressed as % of control (% of response 50ЊC before NT) over time.
ciceptive transmmision. These results support the existence of distinct, independent descending systems through which Descending spinal pathways neurotensin is interacting in the RVM to differentially modulate spinal nociceptive transmission. Neuronal projections from the RVM descend through the spinal funiculi and terminate on spinal dorsal horn neurons in laminae I-III and V-VII (Basbaum and Fields 1979;  
Neurotensin receptors in the RVM
injected at a dose previously reported to cause a short-lived inhibition of spinal nociceptive transmission (Zhuo and The nonpeptide neurotensin receptor antagonist SR48692 Gebhart 1990a . Because L-glutamate was found to (Gully et al. 1993) was used in the current study to confirm be effective in inhibiting spinal nociceptive transmission folthat neurotensin effects in the RVM on spinal nociceptive lowing SR48692 / neurotensin injection, the prevention of transmission were neurotensin receptor mediated. SR48692 neurotensin-induced inhibition by SR48692 was likely due has been previously used as a tool to discriminate potential to a selective block of the neurotensin receptor. The selective neurotensin receptor subtypes. Dubuc et al. (1994) found block of neurotensin induced-inhibition, but not facilitation, SR48692 to inhibit neurotensin-induced hypomotility, but suggests a possible interaction with multiple neurotensin renot hypothermia or analgesia in the mouse and rat. In a ceptor subtypes. This notion is supported by the large differseparate study, SR48692 was shown to inhibit neurotensin-ence in doses required for the production of these effects. induced hypomotility, but not stimulation of dopamine re-These results are consistent with data demonstrating that lease in the nucleus accumbens (Steinberg et al. 1994 ). SR48692 blocks neurotensin-induced inhibition but not faAdditionally, SR48692 was found to be ineffective in inhib-cilitation of the tail-flick reflex following sequential RVM iting neurotensin-induced excitation of substantia nigra neu-injection in awake rats . The results rons in vitro (Pinnock and Woodruff 1994) . This selective from that study support the existence of multiple neurotensin inhibition of neurotensin effects by SR48692 suggests the receptors within the RVM that can be discriminated by existence of potential neurotensin receptor subtypes within SR48692. Interestingly, the dose range found to selectively the CNS. In the current study, injection of SR48692 into the block neurotensin-induced inhibition of the tail-flick reflex RVM had no effect on either spontaneous unit activity or (0.03-30 fmol) is consistent with the dose of SR48692 heat-evoked activity of spinal neurons, suggesting that neu-found to selectively block inhibition of spinal nociceptive rotensin in the RVM does not have a tonic action. However, transmission by neurotensin in the current study (30 fmol). SR48692 injection into the RVM blocked neurotensin-induced inhibition, but not facilitation of spinal nociceptive Cardiovascular effects transmission. To preclude the possibility that the lack of effect of neurotensin was the result of nonselective inactivaIn the current study, injection of neurotensin into the RVM in doses that facilitated and inhibited spinal nociceptive tion of the RVM by SR48692, L-glutamate was subsequently
